1 year return (CAGR)
-52.09%
Sonnet Biotherapeutics Holdings Inc Exchange (NASDAQ, USD)
SONN
-
-1.84 (-59.35%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
8.60M
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 3.16 |
| Daily high | 3.23 |
| Daily low | 1.26 |
| Daily Volume | 8.64M |
| 1y analyst estimate | 20.00 |
| Beta | 1.47 |
| EPS (TTM) | -3.42 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SONN | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.85% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 2 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -100.00% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 288 days | 1805 days |
News
No items found